Glycobiarsol
Glycobiarsol (trade name Milibis) is an antiprotozoal agent that has been used in humans[1] as well as in dogs.[2]
![]()  | |
![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 Oxobismuthanyl hydrogen [4-(2-hydroxyacetamido)phenyl]arsonate  | |
| Other names
 [4-[(2-Hydroxyacetyl)amino]phenyl]-oxobismuthanyl-oxyarsinic acid  | |
| Identifiers | |
3D model (JSmol)  | 
|
| ChemSpider | |
| ECHA InfoCard | 100.003.767 | 
| EC Number | 
  | 
| KEGG | |
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C8H9AsBiNO6 | |
| Molar mass | 499.063 g·mol−1 | 
| Pharmacology | |
| P01AR03 (WHO) QP51AD03 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
References
    
- Berberian, D. A. (1954). "The trichomonacidal activity of milibis (glycobiarsol)". New York State Journal of Medicine. 54 (22): 3102–3105. PMID 13214428.
 - Kibble, R. M. (1969). "Glycobiarsol for the control of Trichuris vulpis infection in the dog". Australian Veterinary Journal. 45 (8): 387. doi:10.1111/j.1751-0813.1969.tb06633.x. PMID 5389346.
 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

